NasdaqGS:ANSS
NasdaqGS:ANSSSoftware

ANSYS (ANSS) Is Up 6.3% After Partnering With iPronics to Boost Photonic Chip Design

  • Earlier this month, Ansys and iPronics announced a collaboration to integrate Ansys' multiphysics simulation tools into iPronics' workflow, advancing fabrication-tolerant photonic integrated circuits for AI and cloud data centers.
  • This partnership highlights Ansys' growing presence in the photonics industry, applying its solutions to high-impact, energy-efficient optical technologies essential for next-generation workloads.
  • We'll explore how Ansys' support for...
NYSE:KVUE
NYSE:KVUEPersonal Products

Kenvue (NYSE:KVUE) Appoints Kirk Perry As Interim CEO For Transformation Initiative

Kenvue (NYSE:KVUE) recently experienced a 2% price increase over the past week, a move that coincides with notable executive changes. The replacement of the CEO with Kirk L. Perry as interim CEO, along with the company's strategic review, likely influenced investor sentiment. Meanwhile, broader market trends remained flat amid geopolitical uncertainties and cryptocurrency rallies, which added mixed sentiments to stock prices overall. Thus, while internal company changes contributed to...
NasdaqCM:RGTI
NasdaqCM:RGTISemiconductor

Rigetti Computing (NasdaqCM:RGTI) Completes $350M Equity Offering

Rigetti Computing (NasdaqCM:RGTI) experienced a notable share price movement, increasing by 41% over the last quarter. This shift coincided with its transition from value-oriented to growth-focused indexes, suggesting a re-evaluation of its market positioning. The company's strategic realignment under growth benchmarks appears to have played a role in this valuation change. While the broader market remained flat amid ongoing trade uncertainties, Rigetti's refined index listings and...
NasdaqGS:TLRY
NasdaqGS:TLRYPharmaceuticals

Tilray Brands (NasdaqGS:TLRY) Soars 44% In Last Month

Tilray Brands (NasdaqGS:TLRY) saw its share price surge by 44% over the last month, a notable change considering recent corporate actions and external market dynamics. The recent announcements from Tilray Medical on cannabinoid formulations and the unveiling of a summer cannabis collection highlight the company's continuous product innovation, potentially attracting investor interest. However, the company's removal from several key indices and the pause on implementing a reverse stock split...